Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers

K Lavudi, SM Nuguri, Z Olverson… - Frontiers in Cell and …, 2023 - frontiersin.org
Retinoic acid (RA) is a vital metabolite derived from vitamin A. RA plays a prominent role
during development, which helps in embryological advancement and cellular differentiation …

The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy

J Sun, L Yu, X Qu, T Huang - Frontiers in Pharmacology, 2023 - frontiersin.org
Peroxisome proliferator-activated receptors (PPARs) have been extensively studied for over
3 decades and consist of three isotypes, including PPARα, γ, and β/δ, that were originally …

Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy

Q Gou, X Gong, J **, J Shi, Y Hou - Oncotarget, 2017 - pmc.ncbi.nlm.nih.gov
Peroxisome-proliferator-activated receptors (PPARs) are nuclear hormone receptors
including PPARα, PPARδ and PPARγ, which play an important role in regulating cancer cell …

PPARγ agonist pioglitazone enhances colorectal cancer immunotherapy by inducing PD-L1 autophagic degradation

X Jia, J Qian, H Chen, Q Liu, S Hussain, J **… - European Journal of …, 2023 - Elsevier
Abstract Blockade of PD-1/PD-L1 immune checkpoint could be an effective antitumor
strategy for multiple types of cancer, but it is low response rate for colorectal cancer patients …

PPARγ inhibited tumor immune escape by inducing PD‐L1 autophagic degradation

Q Gou, S Che, M Chen, H Chen, J Shi, Y Hou - Cancer Science, 2023 - Wiley Online Library
Blockade of the programmed death 1 (PD‐1)/programmed death ligand 1 (PD‐L1) immune
checkpoint could increase antitumor immunotherapy for multiple types of cancer, but the …

Dual function of activated PPARγ by ligands on tumor growth and immunotherapy

M Chen, H Wang, Q Cui, J Shi, Y Hou - Medical Oncology, 2024 - Springer
As one of the peroxisome-proliferator-activated receptors (PPARs) members, PPARγ is a
ligand binding and activated nuclear hormone receptor, which is an important regulator in …

Calcium homeostasis disruption-a bridge connecting cadmium-induced apoptosis, autophagy and tumorigenesis

X Zhou, W Hao, H Shi, Y Hou, Q Xu - Oncology Research and Treatment, 2015 - karger.com
Calcium and cadmium are divalent metals and have similar chemical properties. Both can
enter cells through, albeit different, channels, or through protein-dependent permeation …

GSK0660 enhances antitumor immunotherapy by reducing PD-L1 expression

B Khan, M Chen, H Wang, A Khan, S Hussain… - European Journal of …, 2024 - Elsevier
Abstract Blockade of PD-1/PD-L1 immune checkpoint is wildly used for multiple types of
cancer treatment, while the low response rate for patients is still completely unknown. As …

microRNA‐10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer

K Wu, Y Hu, K Yan, Y Qi, C Zhang… - Journal of Cellular …, 2020 - Wiley Online Library
It is well known that the acquisition of chemoresistance is a major obstacle for the effective
treatment of human cancers. It is reported that microRNAs (miRNAs) are implicated in …

PPARγ agonist inhibits c‐Myc‐mediated colorectal cancer tumor immune escape

L Xu, S Che, H Chen, Q Liu, J Shi… - Journal of Cellular …, 2023 - Wiley Online Library
As a master transcription factor, c‐Myc plays an important role in promoting tumor immune
escape. In addition, PPARγ (peroxisome proliferator‐activated receptor γ) regulates cell …